Fundraising Fox20/20 HealthCare Partners LLC — Full Portfolio
17 tracked investments · listed companies and verified rows first
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investorsBosch VenturesNew Era Capital PartnersOrbiMedPeregrine VenturesPitangoQuark Venture Inc.+2 more
Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics.
BiotechDeep TechHealthtechMedical Devices
PartnerHillel Bachrach· solo GP
Co-investorsGood Growth CapitalNew World AngelsService Provider Capital
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
PartnerHillel Bachrach· led
Co-investorsDolby Family VenturesFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesBioverge+1 more
Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.
BiotechHealthtechRockville, US
Gregory Plan Crimmins(Executive Officer, Director)
PartnerHillel Bachrach· solo GP
Co-investorsSchooner CapitalAlexandria
UltraSPECT develops image reconstruction technology that enables lower-dose and faster nuclear cardiology, oncology, and bone imaging exams.
AI & Machine LearningHealthtechMedical Devices
PartnerHillel Bachrach· solo GP
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
PartnerHillel Bachrach· led
Co-investorsHighlight CapitalYonghua Capital
XR therapeutics platform company that merged with Amelia Virtual Care.
HealthtechNeedham, US
Eran Orr(Founder & Chief Executive Officer)in
PartnerHillel Bachrach· solo GP
Co-investorsAI CapitalAsabys PartnersBridges IsraelFlying Tiger CapitalKeyhorse CapitalCriteria Venture Tech+2 more
Zixi provides software solutions for broadcast and live video workflows, serving content owners, broadcasters, service providers, sports organizations, and OTT providers with capabilities for content contribution, satellite replacement, B2B distribution, and direct-to-consumer enablement.
Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS
Uri Avni(Co-Founder, CTO)
PartnerHillel Bachrach· led
Co-investorsSchooner Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corindus Vascular RoboticsEnclearHighRadNEMDXPhysIQQBiotixSQZ BiotechnologyVelocompViztek
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.